"We believe the severe lung inflammation seen in these advanced patients may be specifically IL-6 mediated," she said in an email.

Regeneron, which is based in Tarrytown, has said previously that it could have up to 200,000 doses of its treatment available by August. The company employs 3,000 people at its Rensselaer County facilities, where large-scale production would take place.

The University at Albany also has the RNA Institute, which has helped developed tests for the Ebola virus. The coronavirus is a type of RNA virus, and so studying RNA is critical for developing testing, treatments and vaccines for COVID-19.

"We make the early-stage discoveries and develop tools that other front line medical researchers and clinicians can translate into breakthroughs in human health," RNA Institute spokesman Vinny Reda said. "As such in the months and years ahead, our researchers will be working diligently to understand the role RNA plays in this health crisis and other critical events."